In response to physiological or psychological challenges, the brain activates behavioral and neuroendocrine systems linked to both metabolic and emotional outputs designed to adapt to the demand. However, dysregulation of integration of these physiological responses to challenge can have severe psychological and physiological consequences, and inappropriate regulation, disproportional intensity, or chronic or irreversible activation of the stress response is linked to the etiology and pathophysiology of mood and metabolic disorders. Using a transgenic mouse model and lentiviral approach, we demonstrate the involvement of the hypothalamic neuropeptide Urocortin-3, a specific ligand for the type-2 corticotropin-releasing factor receptor, in modulating septal and hypothalamic nuclei responsible for anxiety-like behaviors and metabolic functions, respectively. These results position Urocortin-3 as a neuromodulator linking stress-induced anxiety and energy homeostasis and pave the way toward better understanding of the mechanisms that mediate the reciprocal relationships between stress, mood and metabolic disorders.metabolic disorders | mood disorders | corticotropin-releasing factor (CRF) | CRF receptor type 2 | stress response I n modern Western societies, the high stress load correlates with an increasing incidence of mood disorders and metabolic syndrome, both of which have reached epidemic proportions over the past decades (1, 2). Exposure to acute or chronic stress is associated with derangement of metabolic and behavioral homeostasis that contributes to the clinical presentation of visceral obesity, type 2 diabetes, atherosclerosis, and metabolic syndrome (2-4). The corticotropin-releasing factor (CRF) neuropeptide system is the primary central mediator of the stress response and contributes to the etiology of stress-related psychiatric illness (5-8). Studies conducted using CRF receptor type 2 (CRFR2)-null mice or Urocortin-2 (Ucn2)-null mice provided evidence that, in addition to its role in mediating stress-related behavior, central CRFR2 is important in modulating metabolic rate, appetite, and feeding behaviors (9-12).The Urocortin-3 (Ucn3) neuropeptide selectively binds and activates CRFR2. Ucn3 is expressed predominately within the hypothalamus, in the median preoptic nucleus and the rostral perifornical area (rPFA) (13-15). The major rPFA-Ucn3 terminal fields, the lateral septum (LS) and the ventromedial hypothalamus (VMH), express high levels of CRFR2 (15). Different stressors and homeostatic insults influence Ucn3 expression levels, suggesting its position as a potential modulator of the stress response (13,16).To assess the functional relevance of endogenous rPFA-Ucn3 neuronal pathways, activating the CRFR2 both in the LS and the VMH, in mediating behavioral and metabolic responses to challenge, we used a site-specific and inducible genetic approach in vivo. We report that rPFA-Ucn3 overexpression induces an anxiety-like behavior, increases the respiratory exchange ratio (RER) and heat production, an...